CDC reports promising results from CAPRISA microbicide trial showing tenofovir-based vaginal gel may help women prevent HIV infection and reduce genital herpes risk....
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. AcceptRead More
